Hyfacol

Medical-grade collagen manufacturing platform for advanced wound care and guided bone regeneration products

Leeds, United KingdomFounded 2023hyfacol.co.ukWebsite technologies

+ Add to sales board

Highlights

  • Young companyFounded 2023
  • New on EvolcAdded 2026-11-10

About Hyfacol

HyFaCol develops a collagen manufacturing platform intended to improve the production and quality of medical-grade collagen for advanced wound care and guided bone regeneration. Its technology is preparing to enter the human clinical trial process.

The company was developed at the University of Leeds by a team with academic and industry expertise in biomaterials, polymer science and medical device development. Its platform targets manufacturers and markets for collagen-based and other wound-care and bone-regeneration products.

HYFACOL LIMITED was founded in 2023 and is headquartered in Leeds, UK. The company reports patents granted in key EU and US markets and institutional and grant funding invested in platform development.

Product: A collagen manufacturing platform for producing medical-grade collagen for advanced wound care and guided bone regeneration applications.

Jobs at Hyfacol

No open positions listed right now.

Leadership

More biotech & pharma companies

  • Hypha Discovery

    Specialist CRO making drug and agrochemical metabolites, purifying compounds and running MetID studies for pharma clients
    Abingdon, United KingdomBiotech & pharmaFounded 2004
    New on Evolc
  • Ilc Therapeutics

    Develops hybrid interferon therapeutics, with lead candidate Alfacyte in development as an antiviral for RSV
    Edinburgh, United KingdomBiotech & pharmaFounded 2012
    New on Evolc
  • Imaging Endpoints

    Oncology imaging CRO that designs, reads and analyses imaging endpoints for pharma sponsors' clinical trials
    Harrow, United KingdomBiotech & pharmaFounded 2021
    New on Evolc
  • immunesystems.co.uk

    UK supplier of antibodies, ELISA kits, labeling kits and lab reagents for life sciences researchers and producers
    United KingdomBiotech & pharma
    New on Evolc
  • Immunocore

    Biotech developing ImmTAX-based T cell receptor therapies for cancer, infectious and autoimmune diseases
    Abingdon, United KingdomBiotech & pharmaFounded 2007
    New on Evolc
  • Immunokey

    Develops CAR T-cell therapies for solid cancers, starting with ovarian cancer
    Wilmslow, United KingdomBiotech & pharmaFounded 2024
    Young companyNew on Evolc

All biotech & pharma companies →

Website technologies

Tools and platforms detected on this company’s website, grouped by purpose. Dates record when Evolc observed them.

Analytics

  • Google Analytics 4High confidence
    First detected
    Last detected
    Last checked
    Detection evidence
  • Google Tag ManagerMedium confidence
    First detected
    Last detected
    Last checked
    Detection evidence

Content management

  • WordPressHigh confidence
    First detected
    Last detected
    Last checked
    Detection evidence

Frontend frameworks

  • jQueryHigh confidence
    First detected
    Last detected
    Last checked
    Detection evidence

Website detection does not establish a paid subscription or company-wide use. Tools loaded after consent or sign-in may be missed. “No longer observed” does not prove the company stopped using a tool.